Name: Kyverna Therapeutics, Inc. (KYTX) Balance Sheet
Creator: FinSpry

Kyverna Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Kyverna Therapeutics, Inc. (KYTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	96.62	34.65	37.74	76.07
Short-Term Investments	189.36	22.90	13.59	0.00
Cash & Short-Term Investments	285.98	57.54	51.32	76.07
Accounts Receivable	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	4.62	3.12	1.93	1.02
Total Current Assets	290.60	60.66	53.25	77.09
Non-Current Assets
Property, Plant & Equipment (Net)	10.66	10.61	12.44	7.81
Other Non-Current Assets	3.39	3.92	1.23	0.59
Total Non-Current Assets	14.04	14.53	13.67	8.40
Total Assets	304.65	75.20	66.92	85.49
Current Liabilities
Accounts Payable	4.62	4.36	1.45	0.77
Short-Term Debt	3.94	0.00	0.00	0.00
Accrued Liabilities	11.13	9.77	7.66	6.63
Deferred Revenue	0.00	0.00	0.00	6.00
Other Current Liabilities	14.06	3.52	0.57	0.58
Total Current Liabilities	33.76	19.86	11.95	15.93
Non-Current Liabilities
Long-Term Debt	4.30	6.16	8.29	4.74
Other Non-Current Liabilities	0.00	0.00	0.01	0.08
Total Non-Current Liabilities	4.30	186.73	128.97	115.81
Total Liabilities	38.06	206.59	20.25	131.74
Stockholders' Equity
Retained Earnings	-263.52	-136.04	-75.68	-46.78
Accumulated Other Comprehensive Income	0.11	0.00	-0.03	0.00
Additional Paid-in Capital	530.00	4.64	1.71	0.53
Shares Outstanding	43.21	43.12	40.82	40.82
Total Stockholders' Equity	266.59	-131.40	46.68	-46.25
Total Liabilities & Equity	304.65	75.20	66.92	85.49